125 related articles for article (PubMed ID: 18282234)
41. Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
Gallo O; Gori AM; Attanasio M; Martini F; Giusti B; Boddi M; Gallina E; Fini O; Abbate R
Br J Cancer; 1993 Sep; 68(3):465-8. PubMed ID: 8353036
[TBL] [Abstract][Full Text] [Related]
42. Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids.
Furbert-Harris PM; Laniyan I; Harris D; Dunston GM; Vaughn T; Abdelnaby A; Parish-Gause D; Oredipe OA
Anticancer Res; 2003; 23(1A):71-8. PubMed ID: 12680196
[TBL] [Abstract][Full Text] [Related]
43. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
[TBL] [Abstract][Full Text] [Related]
44. [Autologous lymphocytotoxicity against squamous cell carcinoma in head and neck. I. In vitro culture of squamous cell carcinoma in head and neck (author's transl)].
Ikawa T
Nihon Jibiinkoka Gakkai Kaiho; 1981 Dec; 84(12):1570-8. PubMed ID: 7341742
[No Abstract] [Full Text] [Related]
45. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival.
Italiano A; Ortholan C; Dassonville O; Poissonnet G; Thariat J; Benezery K; Vallicioni J; Peyrade F; Marcy PY; Bensadoun RJ
Cancer; 2008 Dec; 113(11):3160-8. PubMed ID: 18932260
[TBL] [Abstract][Full Text] [Related]
46. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
Masserot C; Peffault de Latour R; Rocha V; Leblanc T; Rigolet A; Pascal F; Janin A; Soulier J; Gluckman E; Socié G
Cancer; 2008 Dec; 113(12):3315-22. PubMed ID: 18831513
[TBL] [Abstract][Full Text] [Related]
47. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines.
Ahn YO; Lee JC; Sung MW; Heo DS
J Immunol; 2009 May; 182(10):6114-20. PubMed ID: 19414763
[TBL] [Abstract][Full Text] [Related]
48. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
49. Test system for trifunctional antibodies in 3D MCTS culture.
Hirschhaeuser F; Leidig T; Rodday B; Lindemann C; Mueller-Klieser W
J Biomol Screen; 2009 Sep; 14(8):980-90. PubMed ID: 19675312
[TBL] [Abstract][Full Text] [Related]
50. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
[TBL] [Abstract][Full Text] [Related]
51. Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma.
Croce MV; Rabassa ME; Pereyra A; Segal-Eiras A
Head Neck; 2008 May; 30(5):647-57. PubMed ID: 18302268
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.
Matsui M; Kishida T; Nakano H; Yoshimoto K; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Yoshimoto T; Hisa Y; Mazda O
Cancer Res; 2009 Mar; 69(6):2523-30. PubMed ID: 19244121
[TBL] [Abstract][Full Text] [Related]
53. Protective mechanisms of head and neck squamous cell carcinomas from immune assault.
Young MR
Head Neck; 2006 May; 28(5):462-70. PubMed ID: 16284974
[TBL] [Abstract][Full Text] [Related]
54. Prediction of simultaneous esophageal lesions in head and neck squamous cell carcinoma: a multivariate analysis.
Chow TL; Lee DT; Choi CY; Chan TT; Lam SH
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):882-5. PubMed ID: 19770420
[TBL] [Abstract][Full Text] [Related]
55. Neural cell adhesion molecule expression: no correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck.
Solares CA; Brown I; Boyle GM; Parsons PG; Panizza B
Head Neck; 2009 Jun; 31(6):802-6. PubMed ID: 19283849
[TBL] [Abstract][Full Text] [Related]
56. Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2.
Janke M; Peeters B; Zhao H; de Leeuw O; Moorman R; Arnold A; Ziouta Y; Fournier P; Schirrmacher V
Int J Oncol; 2008 Oct; 33(4):823-32. PubMed ID: 18813797
[TBL] [Abstract][Full Text] [Related]
57. Cellular interaction regulates interleukin-8 secretion by granulosa-lutein cells and monocytes/macrophages.
Połeć A; Tanbo T; Fedorcsák P
Am J Reprod Immunol; 2009 Jan; 61(1):85-94. PubMed ID: 19086996
[TBL] [Abstract][Full Text] [Related]
58. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis.
Berres ML; Schnyder B; Yagmur E; Inglis B; Stanzel S; Tischendorf JJ; Koch A; Winograd R; Trautwein C; Wasmuth HE
Liver Int; 2009 Apr; 29(4):536-43. PubMed ID: 18795898
[TBL] [Abstract][Full Text] [Related]
60. Prognostic factors of unknown primary head and neck squamous cell carcinoma.
Huang CC; Tseng FY; Yeh TH; Wen YH; Hsu CJ; Ko JY; Lou PJ; Chen YS
Otolaryngol Head Neck Surg; 2008 Sep; 139(3):429-35. PubMed ID: 18722226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
